MIMEDX GROUP, INC. — Investor Relations & Filings
Filings indexed
1,093
across all filing types
Latest filing
2026-04-29
Annual Report
Country
US
United States of America
Listing
US
MDXG
MIMEDX GROUP, INC. is a biopharmaceutical company specializing in placental biologics. As a pioneer in the field, the company develops and distributes human placental tissue allografts using proprietary, patent-protected processes. These therapeutic products are designed for applications in advanced wound care, surgical procedures, and burn treatment. MIMEDX's portfolio is supported by extensive scientific and clinical evidence, aiming to provide innovative solutions that elevate the standard of care for patients and healthcare professionals. The company also focuses on ensuring broad patient access to its therapies through comprehensive payer insurance coverage.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - MIMEDX GROUP, INC. (0001376339) (Filer) | 2026-04-29 | English | |
| 8-K - MIMEDX GROUP, INC. (0001376339) (Filer) | 2026-04-16 | English | |
| 4 - MIMEDX GROUP, INC. (0001376339) (Issuer) | 2026-03-17 | English | |
| 4 - MIMEDX GROUP, INC. (0001376339) (Issuer) | 2026-03-17 | English | |
| 8-K - MIMEDX GROUP, INC. (0001376339) (Filer) | 2026-02-25 | English | |
| 10-K - MIMEDX GROUP, INC. (0001376339) (Filer) | 2026-02-25 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 38814941 | ARS - MIMEDX GROUP, INC. (0001376339) (Filer) | 2026-04-29 | English | ||
| 34647175 | 8-K - MIMEDX GROUP, INC. (0001376339) (Filer) | 2026-04-16 | English | ||
| 32968416 | 4 - MIMEDX GROUP, INC. (0001376339) (Issuer) | 2026-03-17 | English | ||
| 32968407 | 4 - MIMEDX GROUP, INC. (0001376339) (Issuer) | 2026-03-17 | English | ||
| 32890902 | 8-K - MIMEDX GROUP, INC. (0001376339) (Filer) | 2026-02-25 | English | ||
| 32890903 | 10-K - MIMEDX GROUP, INC. (0001376339) (Filer) | 2026-02-25 | English | ||
| 32890901 | 4 - MIMEDX GROUP, INC. (0001376339) (Filer) | 2026-02-19 | English | ||
| 29203732 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 29203891 | 8-K Filing | 2026-01-12 | English | ||
|
2025
6 filings
| |||||
| 12040562 | FORM 4 | 2025-11-10 | English | ||
| 12040563 | Regulatory Filings 2025 | 2025-11-06 | English | ||
| 12040567 | 8-K | 2025-10-29 | English | ||
| 12040568 | 10-Q | 2025-10-29 | English | ||
| 12040569 | 8-K | 2025-09-03 | English | ||
| 12040571 | 8-K | 2025-07-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
MIMEDX GROUP, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32206/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32206 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32206 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32206 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32206}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MIMEDX GROUP, INC. (id: 32206)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.